Burt, R., Warcel, D., & Fielding, A. K. (2018). Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies. Hum Vaccin Immunother.
Styl ChicagoBurt, Richard, Dana Warcel, a Adele K. Fielding. "Blinatumomab, a Bispecific B-cell and T-cell Engaging Antibody, in the Treatment of B-cell Malignancies." Hum Vaccin Immunother 2018.
Citace podle MLABurt, Richard, Dana Warcel, a Adele K. Fielding. "Blinatumomab, a Bispecific B-cell and T-cell Engaging Antibody, in the Treatment of B-cell Malignancies." Hum Vaccin Immunother 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..